Diagnostic Utility of Presepsin in Infections After Liver Transplantation: A Preliminary Study

Takahiro Yokose; Masashi Takeuchi; Hideaki Obara; Masahiro Shinoda; Hirofumi Kawakubo; Minoru Kitago; Hiroshi Yagi; Yuta Abe; Yohei Yamada; Kentaro Matsubara; Go Oshima; Shutaro Hori; Takumi Fujimura; Ryo Takemura; Ryota Ishii; Tatsuo Kuroda; Yuko Kitagawa

doi:10.12659/AOT.933774

19 November 2021 : Original article

Diagnostic Utility of Presepsin in Infections After Liver Transplantation: A Preliminary Study

Takahiro Yokose^1ABCDEF, Masashi Takeuchi^1ABCDEF, Hideaki Obara^1ACDEFG*, Masahiro Shinoda^2ADF, Hirofumi Kawakubo^1ADF, Minoru Kitago

^1BCD, Hiroshi Yagi^1BCD, Yuta Abe^1BCD, Yohei Yamada^1BCD, Kentaro Matsubara^1BCD, Go Oshima^1BCD, Shutaro Hori^1BCD, Takumi Fujimura^1BCD, Ryo Takemura^3CD, Ryota Ishii^3CD, Tatsuo Kuroda^1A, Yuko Kitagawa^1AG

DOI: 10.12659/AOT.933774

Ann Transplant 2021; 26:e933774

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 The perioperative kinetics of each marker in all 13 patients(A) Presepsin; (B) Procalcitonin; (C) C-reactive protein (CRP); (D) Leukocyte counts. Left side indicates infection group. Infection occurring after POD 8 (n=3), on POD 2 (n=1), and on POD 7 (n=1) are reported separately. Right side indicates non-infection group. (Microsoft Excel for Macintosh, version 16.16.27, Microsoft).

Back to the Article

Diagnostic Utility of Presepsin in Infections After Liver Transplantation: A Preliminary Study

Your Privacy